Dasatinib (BMS-354825), a dual SRC/ABL kinase inhibitor, inhibits the kinase activity of wild-type, juxtamembrane, and activation loop mutant KIT isoforms associated with human malignancies (Q46882720)
Jump to navigation
Jump to search
scientific article published in January 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Dasatinib (BMS-354825), a dual SRC/ABL kinase inhibitor, inhibits the kinase activity of wild-type, juxtamembrane, and activation loop mutant KIT isoforms associated with human malignancies |
scientific article published in January 2006 |
Statements
1 reference
Dasatinib (BMS-354825), a dual SRC/ABL kinase inhibitor, inhibits the kinase activity of wild-type, juxtamembrane, and activation loop mutant KIT isoforms associated with human malignancies (English)
1 reference
1 reference
1 reference
Carsten Bokemeyer
1 reference
Marcus M Schittenhelm
1 reference
Sharon Shiraga
1 reference
Arin Schroeder
1 reference
Amie S Corbin
1 reference
Diana Griffith
1 reference
Francis Y Lee
1 reference
Michael W N Deininger
1 reference
1 January 2006
1 reference
1 reference
66
1 reference
1
1 reference
473-481
1 reference
Identifiers
1 reference
1 reference